Prevalence, Risk Factors, and Clinical and Biochemical Characteristics of Alemtuzumab-Induced Graves Disease.
Ueland GÅ, Ueland HO, Stokland AM, Bhan A, Schønberg A, Sollid ST, Morgas DE, Holmøy T, Lima K, Methlie P, Løvås K, Torkildsen Ø, Husebye ES.
Ueland GÅ, et al. Among authors: husebye es.
J Clin Endocrinol Metab. 2024 Jan 18;109(2):344-350. doi: 10.1210/clinem/dgad540.
J Clin Endocrinol Metab. 2024.
PMID: 37708353
Free PMC article.